IGM THERAPY IN PREVENTION OF ONSET, PROGRESSION, AND RECURRENCE OF AUTOIMMUNE TYPE 1 DIABETES

摘要

The therapeutic potential of polyclonal serum naturally occurring IgM (nIgM) administration in preventing the onset and progression of autoimmune type 1 diabetes and in promoting graft survival following islet allotransplantation has been investigated. nIgM therapy prevents both, onset and progression of diabetes and promotes islet graft survival.